Sanofi (SNY) Return on Equity (2018)

Sanofi's (SNY) quarterly Return on Equity came in at 0.0% in Q1 2018.

Sanofi (SNY) Return on Equity (2018) Analysis & Trends

Sanofi has disclosed Return on Equity across 1 years of filings, most recently posting 0.0% for Q1 2018.

Return on Equity for Q1 2018 came in at 0.0%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2018 was 0.0% (changed N/A YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
Return on Equity came in at 0.0% for Q1 2018 at Sanofi.
In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2018 to a low of 0.0% in Q1 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROE (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	-
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	0.01%
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	0.00%
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	-0.01%
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	0.00%
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	0.01%
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	0.00%
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	0.00%
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	0.00%
10	Sanofi	63.47 Mn	-6.87 Bn	9.49 Bn	-

Historic Data

Download Data

Date	Value
Mar 31, 2018	0.00%